Boye Mark is a Principal Research Scientist at Eli Lilly and Company, where they have been since 2012, focusing on advanced analytics and health outcomes modeling. They previously served as a Researcher at Eli Lilly and Company from 2006 to 2012 and held managerial roles at Pfizer from 2001 to 2003. Boye earned several degrees, including a PhD in Pharmaceutical Administration from The Ohio State University and an MBA in Marketing from Youngstown State University. They have a strong foundation in health policy, epidemiology, and biostatistics, demonstrated by their various academic achievements.
Location
Indianapolis, United States